← Browse by Condition
Medical Condition
bladder carcinoma
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3, Phase 2
ClinicalMetric tracks all active clinical trials for bladder carcinoma sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — bladder carcinoma Clinical Trials
How many clinical trials are currently recruiting for bladder carcinoma?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for bladder carcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for bladder carcinoma?
bladder carcinoma research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a bladder carcinoma clinical trial?
Eligibility criteria for bladder carcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Phase 3 1
Top Sponsors
2 trials
1 trial
Recruiting Clinical Trials
NCT07067749 Phase 3
Recruiting
Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer
Enrollment
92 pts
Location
Italy
Sponsor
University of Rome Tor Vergata
NCT07285044 Phase 2
Recruiting
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Enrollment
27 pts
Location
United States
Sponsor
Mayo Clinic
NCT06109857
Recruiting
Bladder Bank (a Prospective Banking Study)
Enrollment
1,500 pts
Location
United States
Sponsor
Mayo Clinic
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology